Why the study?
Valve-in-Valve TAVR is a potential solution for malfunctioning surgical aortic valve prostheses, but limited data exist regarding its use in Perceval valves.
Is Valve-in-Valve TAVR feasible and safe in patients with degenerated Perceval surgical aortic valve prostheses?
Population
57 patients with degenerated Perceval bioprostheses from 27 case reports and 6 case series
Comparison
Balloon-expanding vs self-expanding transcatheter heart valves
Design
Systematic review of published case reports and case series
Follow-up
Average 9.8 ± 8.9 months
Authors
Loading...
VIV TAVR may be feasible for degenerated Perceval valves in selected patients; leaves open need for prospective outcome and durability data.
Is Valve-in-Valve TAVR feasible and safe in patients with degenerated Perceval surgical aortic valve prostheses?
VIV-TAVR is a feasible option for degenerated Perceval surgical valves, demonstrating effective gradient reduction but carrying a 15.7% complication rate.
Owais et al. (2024) studied this question.